These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 28427726)
1. A 20-Year-Old Woman With Severe Opioid Toxicity. Solomon R J Emerg Nurs; 2018 Jan; 44(1):77-78. PubMed ID: 28427726 [No Abstract] [Full Text] [Related]
2. Naloxone (Narcan) nasal spray for opioid overdose. Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239 [No Abstract] [Full Text] [Related]
3. Case 37-2017. A 36-Year-Old Man with Unintentional Opioid Overdose. Raja AS; Miller ES; Flores EJ; Wakeman SE; Eng G N Engl J Med; 2017 Nov; 377(22):2181-2188. PubMed ID: 29171813 [No Abstract] [Full Text] [Related]
4. An increase in per-patient naloxone requirements in an opioid epidemic. Birmingham LE; Nielson JA Am J Emerg Med; 2017 Dec; 35(12):1958-1959. PubMed ID: 28633907 [No Abstract] [Full Text] [Related]
5. Intranasal Naloxone for Opioid Overdose. Taylor JL; Lasser KE JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose. Krieter P; Chiang N; Gyaw S; Skolnick P; Crystal R; Keegan F; Aker J; Beck M; Harris J J Clin Pharmacol; 2016 Oct; 56(10):1243-53. PubMed ID: 27145977 [TBL] [Abstract][Full Text] [Related]
7. Treatment of opioid overdose: a brief review of naloxone pharmacology and delivery. Hendley TM; Hersh EV; Moore PA; Stahl B; Saraghi M Gen Dent; 2017; 65(3):18-21. PubMed ID: 28475079 [No Abstract] [Full Text] [Related]
9. Reversal of Pediatric Opioid Toxicity with Take-Home Naloxone: a Case Report. Lebin JA; Chen BC; Valento MJ J Med Toxicol; 2019 Apr; 15(2):134-135. PubMed ID: 30632074 [TBL] [Abstract][Full Text] [Related]
10. Opioid education and nasal naloxone rescue kits in the emergency department. Dwyer K; Walley AY; Langlois BK; Mitchell PM; Nelson KP; Cromwell J; Bernstein E West J Emerg Med; 2015 May; 16(3):381-4. PubMed ID: 25987910 [TBL] [Abstract][Full Text] [Related]
11. Naloxone prescribing: room for finesse. Gilham J; Lloyd G Br J Hosp Med (Lond); 2019 Mar; 80(3):C46-C48. PubMed ID: 30860915 [No Abstract] [Full Text] [Related]
12. The Rising Price of Naloxone - Risks to Efforts to Stem Overdose Deaths. Gupta R; Shah ND; Ross JS N Engl J Med; 2016 Dec; 375(23):2213-2215. PubMed ID: 27959694 [No Abstract] [Full Text] [Related]
13. Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose. Yokell MA; Zaller ND; Green TC; McKenzie M; Rich JD J Opioid Manag; 2012; 8(1):63-6. PubMed ID: 22479887 [TBL] [Abstract][Full Text] [Related]
14. Rapid induction onto sublingual buprenorphine after opioid overdose and successful linkage to treatment for opioid use disorder. Herring AA; Schultz CW; Yang E; Greenwald MK Am J Emerg Med; 2019 Dec; 37(12):2259-2262. PubMed ID: 31239086 [No Abstract] [Full Text] [Related]
15. Factors associated with naloxone administration in an opioid dependent sample. Kenney SR; Anderson BJ; Bailey GL; Stein MD J Subst Abuse Treat; 2018 Jan; 84():17-20. PubMed ID: 29195589 [TBL] [Abstract][Full Text] [Related]
17. Dying alone: the sad irrelevance of naloxone in the context of solitary opiate use. Wojcicki JM Addiction; 2019 Mar; 114(3):574-575. PubMed ID: 30461114 [No Abstract] [Full Text] [Related]
18. Naloxone Conundrum: Reduce risk in managing the opioid overdose patient. Wirth SR JEMS; 2016 Nov; 41(11):14-5. PubMed ID: 29188938 [No Abstract] [Full Text] [Related]
19. Emergency naloxone for heroin overdose: naloxone is not the only opioid antagonist. Brewer C BMJ; 2006 Oct; 333(7571):754-5. PubMed ID: 17023477 [No Abstract] [Full Text] [Related]
20. Higher naloxone dosing may be required for opioid overdose. Bardsley R Am J Health Syst Pharm; 2019 Oct; 76(22):1835-1837. PubMed ID: 31665765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]